A subpopulation of cells that can give rise to pancreatic cancer have been identified by MIT cancer biologists.
They also found that tumors can form in other, more mature pancreatic cell types, but only when they are injured or inflamed, suggesting that pancreatic cancer can arise from different types of cells depending on the circumstances.
Why it matters: There are few good treatment options for pancreatic cancer, which kills an estimated 35,000 Americans per year — making it the country's fourth-leading cause of cancer death. Learning more about the origins of pancreatic cancer cells could help scientists develop better treatments and tools for early diagnosis. "By the time pancreatic disease is typically diagnosed, it's already very advanced and non-curable. Our new findings can help scientists focus their drug development efforts and lead them to new ways to detect the disease in early stages," says Sharon Friedlander, a postdoctoral associate at MIT's David H. Koch Institute for Integrative Cancer Research and lead author of a paper describing the work in the Nov. 3 issue of
Cancer Cell.
How they did it: The team found that in mice, tumors originate from a subpopulation of pancreatic cells that express a protein called pdx1. This protein plays a critical role in pancreas development and differentiation, a process of specialization that normally occurs during embryonic development but can also occur later in life. This suggests that under normal conditions, pancreatic cancer may arise from a type of adult stem cell that can differentiate into mature pancreatic cells, says Friedlander.